SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 71 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $206,946 | +2.0% | 31,789 | +33.6% | 0.01% | -30.0% |
Q4 2022 | $202,937 | +269.0% | 23,791 | +127.3% | 0.01% | +400.0% |
Q3 2022 | $55,000 | +12.2% | 10,468 | -5.7% | 0.00% | +100.0% |
Q2 2022 | $49,000 | +32.4% | 11,104 | +4.4% | 0.00% | 0.0% |
Q1 2022 | $37,000 | -47.1% | 10,640 | +0.3% | 0.00% | 0.0% |
Q4 2021 | $70,000 | -44.0% | 10,605 | -10.2% | 0.00% | -50.0% |
Q3 2021 | $125,000 | -61.5% | 11,809 | +14.7% | 0.00% | -60.0% |
Q2 2021 | $325,000 | -25.3% | 10,295 | -4.0% | 0.01% | -37.5% |
Q1 2021 | $435,000 | – | 10,726 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 3,009,677 | $25,672,544 | 9.37% |
Nextech Invest Ltd. | 1,910,029 | $16,292,547 | 6.48% |
K2 PRINCIPAL FUND, L.P. | 2,872,148 | $24,499,422 | 3.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $94,494,717 | 1.96% |
Orbimed Advisors | 8,740,887 | $74,559,766 | 1.43% |
SECTORAL ASSET MANAGEMENT INC | 782,410 | $6,673,957 | 1.29% |
Rubric Capital Management LP | 2,990,564 | $25,509,511 | 1.11% |
Oasis Management Co Ltd. | 317,662 | $2,709,657 | 0.54% |
RA Capital Management | 3,009,678 | $25,672,553 | 0.52% |
TANG CAPITAL MANAGEMENT LLC | 409,463 | $3,492,719 | 0.51% |